February 28, 2024
Mitsubishi Tanabe Pharma said that its licensing partner Daiichi Sankyo will roll out an intravenous infusion formulation of its amyotrophic lateral sclerosis (ALS) treatment Radicava (edaravone) in Brazil on February 29. Back in 2019, the two companies had sealed a...read more